Global and Japan Gastric Motility Disorder Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 134
Inquire Before Buying

Gastric Motility Disorder Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gastric Motility Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Gastric Motility Disorder Drug market is segmented into

- Velusetrag

- Ipamorelin

- TD-8954

- Others

Segment by Application, the Gastric Motility Disorder Drug market is segmented into

- Hospital

- Clinic

- Home Use

Regional and Country-level Analysis

The Gastric Motility Disorder Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Gastric Motility Disorder Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Gastric Motility Disorder Drug Market Share Analysis

Gastric Motility Disorder Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastric Motility Disorder Drug business, the date to enter into the Gastric Motility Disorder Drug market, Gastric Motility Disorder Drug product introduction, recent developments, etc.

The major vendors covered:

- Theravance, Inc.

- Helsinn Healthcare S.A.

- Concert Pharmaceuticals, Inc.

- Targacept, Inc.

- ChironWells GmbH

- ...

Global and Japan Gastric Motility Disorder Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Gastric Motility Disorder Drug Product Introduction
1.2 Market Segments
1.3 Key Gastric Motility Disorder Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Type
1.4.2 Velusetrag
1.4.3 Ipamorelin
1.4.4 TD-8954
1.4.5 Others
1.5 Market by Application
1.5.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastric Motility Disorder Drug Market Size, Estimates and Forecasts
2.1.1 Global Gastric Motility Disorder Drug Revenue 2015-2026
2.1.2 Global Gastric Motility Disorder Drug Sales 2015-2026
2.2 Global Gastric Motility Disorder Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gastric Motility Disorder Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gastric Motility Disorder Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gastric Motility Disorder Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gastric Motility Disorder Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Gastric Motility Disorder Drug Revenue Forecast by Region (2021-2026)
3 Global Gastric Motility Disorder Drug Competitor Landscape by Players
3.1 Global Top Gastric Motility Disorder Drug Sales by Manufacturers
3.1.1 Global Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gastric Motility Disorder Drug Manufacturers by Revenue
3.2.1 Global Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastric Motility Disorder Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastric Motility Disorder Drug Revenue in 2019
3.2.5 Global Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastric Motility Disorder Drug Price by Manufacturers
3.4 Global Gastric Motility Disorder Drug Manufacturing Base Distribution, Product Types
3.4.1 Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastric Motility Disorder Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastric Motility Disorder Drug Market Size by Type (2015-2020)
4.1.1 Global Gastric Motility Disorder Drug Sales by Type (2015-2020)
4.1.2 Global Gastric Motility Disorder Drug Revenue by Type (2015-2020)
4.1.3 Gastric Motility Disorder Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastric Motility Disorder Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2021-2026)
4.2.3 Gastric Motility Disorder Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastric Motility Disorder Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastric Motility Disorder Drug Market Size by Application (2015-2020)
5.1.1 Global Gastric Motility Disorder Drug Sales by Application (2015-2020)
5.1.2 Global Gastric Motility Disorder Drug Revenue by Application (2015-2020)
5.1.3 Gastric Motility Disorder Drug Price by Application (2015-2020)
5.2 Gastric Motility Disorder Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastric Motility Disorder Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Gastric Motility Disorder Drug Sales YoY Growth 2015-2026
6.1.2 Japan Gastric Motility Disorder Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Gastric Motility Disorder Drug Market Share in Global Market 2015-2026
6.2 Japan Gastric Motility Disorder Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Gastric Motility Disorder Drug Players by Sales (2015-2020)
6.2.2 Japan Top Gastric Motility Disorder Drug Players by Revenue (2015-2020)
6.3 Japan Gastric Motility Disorder Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Gastric Motility Disorder Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Gastric Motility Disorder Drug Price by Type (2015-2020)
6.4 Japan Gastric Motility Disorder Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Gastric Motility Disorder Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Gastric Motility Disorder Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Gastric Motility Disorder Drug Price Forecast by Type (2021-2026)
6.5 Japan Gastric Motility Disorder Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Gastric Motility Disorder Drug Price by Application (2015-2020)
6.6 Japan Gastric Motility Disorder Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Gastric Motility Disorder Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Gastric Motility Disorder Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Gastric Motility Disorder Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
7.2 North America Gastric Motility Disorder Drug Market Facts & Figures by Country
7.2.1 North America Gastric Motility Disorder Drug Sales by Country (2015-2020)
7.2.2 North America Gastric Motility Disorder Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
8.2 Europe Gastric Motility Disorder Drug Market Facts & Figures by Country
8.2.1 Europe Gastric Motility Disorder Drug Sales by Country
8.2.2 Europe Gastric Motility Disorder Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gastric Motility Disorder Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Gastric Motility Disorder Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
10.2 Latin America Gastric Motility Disorder Drug Market Facts & Figures by Country
10.2.1 Latin America Gastric Motility Disorder Drug Sales by Country
10.2.2 Latin America Gastric Motility Disorder Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastric Motility Disorder Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gastric Motility Disorder Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Country
11.2.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Theravance, Inc.
12.1.1 Theravance, Inc. Corporation Information
12.1.2 Theravance, Inc. Description and Business Overview
12.1.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
12.1.5 Theravance, Inc. Recent Development
12.2 Helsinn Healthcare S.A.
12.2.1 Helsinn Healthcare S.A. Corporation Information
12.2.2 Helsinn Healthcare S.A. Description and Business Overview
12.2.3 Helsinn Healthcare S.A. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products Offered
12.2.5 Helsinn Healthcare S.A. Recent Development
12.3 Concert Pharmaceuticals, Inc.
12.3.1 Concert Pharmaceuticals, Inc. Corporation Information
12.3.2 Concert Pharmaceuticals, Inc. Description and Business Overview
12.3.3 Concert Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products Offered
12.3.5 Concert Pharmaceuticals, Inc. Recent Development
12.4 Targacept, Inc.
12.4.1 Targacept, Inc. Corporation Information
12.4.2 Targacept, Inc. Description and Business Overview
12.4.3 Targacept, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products Offered
12.4.5 Targacept, Inc. Recent Development
12.5 ChironWells GmbH
12.5.1 ChironWells GmbH Corporation Information
12.5.2 ChironWells GmbH Description and Business Overview
12.5.3 ChironWells GmbH Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products Offered
12.5.5 ChironWells GmbH Recent Development
12.11 Theravance, Inc.
12.11.1 Theravance, Inc. Corporation Information
12.11.2 Theravance, Inc. Description and Business Overview
12.11.3 Theravance, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
12.11.5 Theravance, Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastric Motility Disorder Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastric Motility Disorder Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Gastric Motility Disorder Drug Market Segments
Table 2. Ranking of Global Top Gastric Motility Disorder Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Velusetrag
Table 5. Major Manufacturers of Ipamorelin
Table 6. Major Manufacturers of TD-8954
Table 7. Major Manufacturers of Others
Table 8. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Gastric Motility Disorder Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Gastric Motility Disorder Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Gastric Motility Disorder Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Gastric Motility Disorder Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Gastric Motility Disorder Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 14. Global Gastric Motility Disorder Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Gastric Motility Disorder Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Gastric Motility Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Motility Disorder Drug as of 2019)
Table 18. Gastric Motility Disorder Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Gastric Motility Disorder Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Gastric Motility Disorder Drug Price (2015-2020) (USD/Pcs)
Table 21. Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gastric Motility Disorder Drug Product Type
Table 23. Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 27. Global Gastric Motility Disorder Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Table 29. Gastric Motility Disorder Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Gastric Motility Disorder Drug Sales Share by Type (2021-2026)
Table 31. Global Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 33. Global Gastric Motility Disorder Drug Sales Share by Application (2021-2026)
Table 34. Global Gastric Motility Disorder Drug Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Gastric Motility Disorder Drug Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan Gastric Motility Disorder Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 38. Japan Gastric Motility Disorder Drug Sales Share by Company (2015-2020)
Table 39. Japan Gastric Motility Disorder Drug Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Type (2015-2020)
Table 41. Japan Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 42. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan Gastric Motility Disorder Drug Price (K Pcs) by Type (2015-2020)
Table 44. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Type (2021-2026)
Table 45. Japan Gastric Motility Disorder Drug Sales Share by Type (2021-2026)
Table 46. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan Gastric Motility Disorder Drug Revenue Share by Type (2021-2026)
Table 48. Japan Gastric Motility Disorder Drug Price (K Pcs) by Type (2021-2026)
Table 49. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Japan Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 51. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Application (2021-2026)
Table 53. Japan Gastric Motility Disorder Drug Sales Share by Application (2021-2026)
Table 54. Japan Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan Gastric Motility Disorder Drug Revenue Share by Application (2021-2026)
Table 56. North America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 57. North America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 58. North America Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 60. Europe Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 61. Europe Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 62. Europe Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2015-2020) (K Pcs)
Table 65. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Table 68. Latin America Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 69. Latin America Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2015-2020) (K Pcs)
Table 73. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country (2015-2020)
Table 76. Theravance, Inc. Corporation Information
Table 77. Theravance, Inc. Description and Business Overview
Table 78. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Theravance, Inc. Gastric Motility Disorder Drug Product
Table 80. Theravance, Inc. Recent Development
Table 81. Helsinn Healthcare S.A. Corporation Information
Table 82. Helsinn Healthcare S.A. Description and Business Overview
Table 83. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Helsinn Healthcare S.A. Product
Table 85. Helsinn Healthcare S.A. Recent Development
Table 86. Concert Pharmaceuticals, Inc. Corporation Information
Table 87. Concert Pharmaceuticals, Inc. Description and Business Overview
Table 88. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Concert Pharmaceuticals, Inc. Product
Table 90. Concert Pharmaceuticals, Inc. Recent Development
Table 91. Targacept, Inc. Corporation Information
Table 92. Targacept, Inc. Description and Business Overview
Table 93. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Targacept, Inc. Product
Table 95. Targacept, Inc. Recent Development
Table 96. ChironWells GmbH Corporation Information
Table 97. ChironWells GmbH Description and Business Overview
Table 98. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. ChironWells GmbH Product
Table 100. ChironWells GmbH Recent Development
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Gastric Motility Disorder Drug Players
Table 105. Gastric Motility Disorder Drug Customers List
Table 106. Gastric Motility Disorder Drug Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastric Motility Disorder Drug Product Picture
Figure 2. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Velusetrag Product Picture
Figure 4. Ipamorelin Product Picture
Figure 5. TD-8954 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Home Use
Figure 11. Gastric Motility Disorder Drug Report Years Considered
Figure 12. Global Gastric Motility Disorder Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastric Motility Disorder Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Gastric Motility Disorder Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastric Motility Disorder Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 17. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 19. Global Gastric Motility Disorder Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastric Motility Disorder Drug Revenue in 2019
Figure 21. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastric Motility Disorder Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2019
Figure 24. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastric Motility Disorder Drug Revenue Market Share by Type in 2019
Figure 26. Global Gastric Motility Disorder Drug Market Share by Price Range (2015-2020)
Figure 27. Global Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2019
Figure 29. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastric Motility Disorder Drug Revenue Market Share by Application in 2019
Figure 31. Japan Gastric Motility Disorder Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 32. Japan Gastric Motility Disorder Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan Gastric Motility Disorder Drug Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest Gastric Motility Disorder Drug Players Market Share by Revenue in Gastric Motility Disorder Drug in 2019
Figure 35. Japan Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Figure 36. Japan Gastric Motility Disorder Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan Gastric Motility Disorder Drug Revenue Share by Application (2015-2020)
Figure 38. Japan Gastric Motility Disorder Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. North America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 42. North America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 43. U.S. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. U.S. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Canada Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 48. Europe Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 50. Europe Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 51. Germany Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Germany Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. France Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. U.K. Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region in 2019
Figure 64. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region in 2019
Figure 65. China Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 90. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gastric Motility Disorder Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Gastric Motility Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Gastric Motility Disorder Drug Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs